Mercury Bio and Meta-Flux Announce Strategic Collaboration to Advance Large-Molecule Therapeutics for Parkinson’s and Alzheimer’s Diseases
SANTA FE, N.M. and CAMBRIDGE, Mass., Dec. 19, 2025 /PRNewswire/ — Mercury Bio, a biotechnology company advancing large-molecule therapeutics for neurodegenerative
2025/12/19